Skip to content

Kidney stones and other calculus build-up seen in 4% of those on Kaletra-based HAART

HAART takes more than a year to suppress Kaposi’s sarcoma virus

CSF abnormalities less likely to normalise in HIV-positive patients treated for neurosyphilis

Can HAART prevent SARS?

Kaletra may cause fewer lipid abnormalities than previously thought in HIV-positive

Kaletra leads to significant increases in some blood lipids in HIV-negative men

Fixed-dose ARV combinations: choices and challenges

Consistent condom use associated with regression of CIN and clearance of HPV in Dutch studies

Cheap tests good predictors of disease progression after starting HAART